Integragen
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and o… Read more
Integragen (ALINT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -1.910x
Based on the latest financial reports, Integragen (ALINT) has a cash flow conversion efficiency ratio of -1.910x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-645.51K) by net assets (€338.04K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Integragen - Cash Flow Conversion Efficiency Trend (2012–2022)
This chart illustrates how Integragen's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Integragen Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Integragen ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Korea Fund Inc
F:KOF1
|
N/A |
|
MT Educare Limited
NSE:MTEDUCARE
|
-0.407x |
|
Rochester Resources Ltd
PINK:RCTFF
|
-0.011x |
|
PCG-P-X
PINK:PCG-P-X
|
N/A |
|
Cannabis Suisse Corp
PINK:CSUI
|
0.012x |
|
Sunrise Communications AG American Depositary Shares representing Class A shares When Issued
NASDAQ:SNREV
|
N/A |
|
XPPT
F:XPPT
|
N/A |
|
ELISA (EIA.SG)
STU:EIA
|
0.156x |
Annual Cash Flow Conversion Efficiency for Integragen (2012–2022)
The table below shows the annual cash flow conversion efficiency of Integragen from 2012 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €2.20 Million | €403.11K | 0.183x | -2.75% |
| 2021-12-31 | €2.19 Million | €411.78K | 0.188x | -9.62% |
| 2020-12-31 | €2.17 Million | €452.69K | 0.208x | +104.19% |
| 2019-12-31 | €2.51 Million | €256.10K | 0.102x | +109.82% |
| 2018-12-31 | €2.79 Million | €135.90K | 0.049x | +55.07% |
| 2017-12-31 | €3.93 Million | €123.30K | 0.031x | -61.91% |
| 2016-12-31 | €1.28 Million | €105.62K | 0.082x | +102.29% |
| 2013-12-31 | €691.87K | €-2.49 Million | -3.592x | -693.04% |
| 2012-12-31 | €3.24 Million | €-1.47 Million | -0.453x | -- |